chartexchange

IBRX Stock Eyes Worst Week In Nearly 2 Years — But Anktiva’s Sepsis Trial Potential Fuels Retail Bets On Big Pharma Appeal

Stocktwits | Nov 11, 2026 10:52 PM EST

Founder Patrick Soon-Shiong said sepsis trials would begin soon in the U.S. and Europe.

Read original article